DS-437
CAS No. 1674364-87-4
DS-437( DS437 | DS 437 )
Catalog No. M12556 CAS No. 1674364-87-4
DS-437 is a potent, selective, dual inhibitor of PRMT5 and PRMT7.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDS-437
-
NoteResearch use only, not for human use.
-
Brief DescriptionDS-437 is a potent, selective, dual inhibitor of PRMT5 and PRMT7.
-
DescriptionDS-437 is a potent, selective, dual inhibitor of PRMT5 and PRMT7 with IC50 of 6.0 uM for both, DS-437 is inactive against 29 other human protein-, DNA-, and RNA-methyltransferases; inhibits methylation of full-length histone 4 by PRMT5-MEP50 with an IC50 of 37 ± 1.2 μM in a biochemical assay; inhibits symmetrical dimethylation of PRMT5 substrates in cells.
-
In Vitro——
-
In VivoAnimal Model:Six to Ten weeks old female Balb/c mice (bearing ?CT26Her2 tumor cells) Dosage:10 mg/kg Administration:i.p.; 5 times a week Result:Had some beneficial effects on inhibiting tumor growth.
-
SynonymsDS437 | DS 437
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1674364-87-4
-
Formula Weight397.454
-
Molecular FormulaC15H23N7O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (314.50 mM)
-
SMILESO=C(NCCSC[C@H]1O[C@@H](N2C=NC3=C(N=CN=C23)N)[C@@H]([C@@H]1O)O)NCC
-
Chemical Name1-[2-[[(2S,3R,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]ethyl]-3-ethylurea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Smil D, et al. ACS Med Chem Lett. 2015 Mar 2;6(4):408-12.
molnova catalog
related products
-
UNC0321
A highly potent, selective G9a inhibitor with Ki of 63 pM; inhibits G9a and GLP with IC50 of 6 nM and 23 nM in CLOT biochemical assays.
-
SGC0946
SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM; selectively kill mixed lineage leukaemia cells.
-
PF-06821497 (b)
PF-06821497 (PF06821497) is a novel potent, selective, orally bioavailable EZH2 inhibitor.
Cart
sales@molnova.com